ÜSKÜDAR TEKE, H. Et Al. 2019. Which Factor Is Responsible for The Prognosis in MyelodysplasticSyndrome Patients with an Isolated Del(5q) or A Cytogenetic Abnormality in Addition to Del(5q): Blast Counts or Cytogenetics?. Hematological Disease and Therapies .

ÜSKÜDAR TEKE, H., ANDIÇ, N., BULDUK, T., GÜNDÜZ, E., BİLGİN, M., AKAY, O. M., ... DURAK ARAS, B.(2019). Which Factor Is Responsible for The Prognosis in MyelodysplasticSyndrome Patients with an Isolated Del(5q) or A Cytogenetic Abnormality in Addition to Del(5q): Blast Counts or Cytogenetics?. Hematological Disease and Therapies .

ÜSKÜDAR TEKE, HAVA Et Al. "Which Factor Is Responsible for The Prognosis in MyelodysplasticSyndrome Patients with an Isolated Del(5q) or A Cytogenetic Abnormality in Addition to Del(5q): Blast Counts or Cytogenetics?," Hematological Disease and Therapies , 2019

ÜSKÜDAR TEKE, HAVA Ü. Et Al. "Which Factor Is Responsible for The Prognosis in MyelodysplasticSyndrome Patients with an Isolated Del(5q) or A Cytogenetic Abnormality in Addition to Del(5q): Blast Counts or Cytogenetics?." Hematological Disease and Therapies , 2019

ÜSKÜDAR TEKE, H. Et Al. (2019) . "Which Factor Is Responsible for The Prognosis in MyelodysplasticSyndrome Patients with an Isolated Del(5q) or A Cytogenetic Abnormality in Addition to Del(5q): Blast Counts or Cytogenetics?." Hematological Disease and Therapies .

@article{article, author={HAVA ÜSKÜDAR TEKE Et Al. }, title={Which Factor Is Responsible for The Prognosis in MyelodysplasticSyndrome Patients with an Isolated Del(5q) or A Cytogenetic Abnormality in Addition to Del(5q): Blast Counts or Cytogenetics?}, journal={Hematological Disease and Therapies}, year=2019}